On November 14, STERIS plc recorded an Intraday Rise of 4.22% in Regular Trading, trading at $264.115 per share, with turnover of $135 million.
The immediate catalyst was a fresh analyst action: Jefferies upgraded STERIS plc to Buy from Hold and set a $305 price target, reinforcing improving sentiment after UBS had also lifted its target to $290 while maintaining a Buy rating.
The upgrade came shortly after the company reported fiscal second-quarter adjusted EPS of $2.94, above the $2.68 consensus, on revenue of $1.59 billion versus expectations of $1.56 billion. Management also raised fiscal adjusted EPS guidance to $11.35-$11.55 from $11.10-$11.30, ahead of the $11.21 market expectation, while keeping projected revenue growth at 7% to 8%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments